Education Library

Resources for Health Care Professionals

Filter Results

Condition

Audience

Topic

Type

June 6, 2022

Revascularization in HFrEF: Studies and Strategies

Kate Kearney, MD, discusses studies and strategies for revascularization in heart failure with reduced ejection fraction.

June 2, 2022

PROTECT IV RCT Underway

Gregg Stone, M.D., presents the newly underway PROTECT IV randomized controlled transcatheter heart failure therapy trial at THT 2022.

May 26, 2022

Impella® Placement Pre-PCI for AMI Cardiogenic Shock  

Mario Iannaccone, MD, discusses his meta-analysis data supporting pre-PCI placement of Impella® for AMI cardiogenic shock.

 

December 7, 2021

Clinical Analysis of Impella® in High-Risk PCI

Alexandra Lansky, MD, discusses a propensity-adjusted population-based analysis of Impella in patients undergoing high-risk PCI from a large-scale claims dataset. 

November 3, 2021

HFSA 2021: Identifying Patients for PROTECT IV

Navin Kapur, MD, explains the importance of identifying patients with heart failure who can be enrolled in the PROTECT IV trial.

November 2, 2021

HFSA 2021: Clinical Evidence to Support ‘On-Pump’ Complex PCI in Heart Failure

Navin Kapur, MD, discusses clinical evidence to support ‘on-pump’ complex PCI for patients with heart failure.

October 26, 2021

HFSA 2021: MCS in High-Risk PCI Evidence from PROTECT II through PROTECT IV

Gregg Stone, MD, reviews available data—from PROTECT II through PROTECT IV—for use of mechanical circulatory support during high-risk PCI.

October 20, 2021

Innovative Single-Access Dry Field Closure Technique

Hady Lichaa, MD, discusses an innovative single-access dry-closure technique with iliac artery angioplasty through the ipsilateral sheath.

August 9, 2021

Study of 21,848 High-Risk PCI Patients Demonstrates Lower Risk of Death and Complications in Patients who Receive PVADs  

A study of 21,848 non-emergent, high-risk patients who underwent PCI with PVADs, including Impella® heart pumps, demonstrates the PVAD patients had a lower rate of mortality and complications than patients who underwent PCI with IABPs.

July 8, 2021

Protected PCI for Superior Long-Term Outcomes

Gregg Stone, MD, and Duane Pinto, MD, host this panel discussion from SCAI 2021 of Protected PCI and diagnosis and treatment of high-risk and complex coronary disease.

June 4, 2021

Ultra-Low Contrast PCI of LM-LAD with LV Mechanical Circulatory Support

Ziad Ali, MD, presents a case study illustrating imaging-guided PCI in the context of high-risk Protected PCI at the CRT 2021 virtual annual symposium. 

May 20, 2021

CRT 2021: PROTECT IV and Beyond with Rajan Patel, MD

Rajan Patel, MD, discusses clinical data supporting Impella® use in Protected PCI and cardiogenic shock at the CRT 2021 virtual annual symposium. 

April 15, 2021

First Patient Enrolled in PROTECT IV Randomized Controlled Trial of Impella® Heart Pumps

The PROTECT IV RCT will leverage advancements in technology and best practices learned since the completion of the PROTECT II RCT and the FDA pre-market approval for Impella 2.5® for high-risk PCI. 

April 8, 2021

Live Case: High-Risk PCI with Atherectomy, Stenting, and Impella® Support

This live case highlights high-risk PCI involving a calcified graft lesion treated with orbital atherectomy and stenting with Impella heart pump hemodynamic support.

February 23, 2021

Impact of Impella® on Dissected Coronary Artery Hemodynamics

Kiyotake Ishikawa, MD, discusses his paper on the impact of Impella on dissected coronary artery hemodynamics in a porcine model.

NPS-1674